Differences in prevalence of prescription opiate misuse among rural and urban probationers.

Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J (2010) 2.06

Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health (2009) 1.53

Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend (2013) 1.19

Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend (2010) 1.15

Distance traveled and cross-state commuting to opioid treatment programs in the United States. J Environ Public Health (2011) 1.03

Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health (2013) 1.02

OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med (2012) 1.00

Prescription opiate misuse among rural stimulant users in a multistate community-based study. Am J Drug Alcohol Abuse (2009) 1.00

Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health (2014) 0.96

Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. Drug Alcohol Depend (2012) 0.91

Examining gender differences in substance use and age of first use among rural Appalachian drug users in Kentucky. Am J Drug Alcohol Abuse (2010) 0.89

Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int J Drug Policy (2014) 0.82

The opiate pain reliever epidemic among U.S. arrestees 2000-2010: regional and demographic variations. J Ethn Subst Abuse (2013) 0.81

Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol (2012) 0.80

HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study. BMC Public Health (2014) 0.80

Correlates of participation in peer recovery support groups as well as voluntary and mandated substance abuse treatment among rural and urban probationers. J Subst Abuse Treat (2011) 0.80

Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Addiction (2016) 0.78

Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics. J Behav Health Serv Res (2015) 0.77

Racial differences in HIV/AIDS discussion strategies and sexual risk behaviors among drug-abusing female criminal offenders. J Psychoactive Drugs (2008) 0.77

Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women. Soc Work Public Health (2015) 0.77

Nonmedical prescription opioid use among victimized women on probation and parole. Addict Behav (2015) 0.76

Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research. J Pharm Pract (2016) 0.75

Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States. Rev Health Care (2014) 0.75

Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003) (2016) 0.75

Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med (2015) 4.50

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain (2005) 4.27

Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med (2007) 3.56

Effect of abuse-deterrent formulation of OxyContin. N Engl J Med (2012) 2.67

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf (2007) 2.65

Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med (2009) 2.13

Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct J (2010) 2.06

Limiting options: sex ratios, incarceration rates, and sexual risk behavior among people on probation and parole. Sex Transm Dis (2012) 1.76

Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain (2008) 1.75

HIV/AIDS among probationers: an assessment of risk and results from a brief intervention. J Psychoactive Drugs (2004) 1.73

The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med (2007) 1.70

Barriers to health and social services for street-based sex workers. J Health Care Poor Underserved (2005) 1.62

Foundations of opioid risk management. Clin J Pain (2007) 1.60

Apc inhibition of Wnt signaling regulates supernumerary tooth formation during embryogenesis and throughout adulthood. Development (2009) 1.59

Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend (2006) 1.51

The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse (2006) 1.47

Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trial. Addiction (2012) 1.43

The "black box" of prescription drug diversion. J Addict Dis (2009) 1.42

Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol (2007) 1.39

Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus (2012) 1.36

Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35

Substance use, health, and mental health: problems and service utilization among incarcerated women. Int J Offender Ther Comp Criminol (2003) 1.32

Prescription drugs purchased through the internet: who are the end users? Drug Alcohol Depend (2010) 1.28

Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance-using MSM. AIDS Educ Prev (2012) 1.28

Temporomandibular joint formation requires two distinct hedgehog-dependent steps. Proc Natl Acad Sci U S A (2009) 1.27

Evaluating component effects of a prison-based treatment continuum. J Subst Abuse Treat (2002) 1.25

Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann (2011) 1.25

Use and misuse of buprenorphine in the management of opioid addiction. J Opioid Manag (2008) 1.25

HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure. J Subst Abuse Treat (2007) 1.21

Prescription drug abuse among ecstasy users in Miami. J Addict Dis (2005) 1.20

Barriers to formal drug abuse treatment in the rural south: a preliminary ethnographic assessment. J Psychoactive Drugs (2008) 1.19

A prospective examination of high-cost health services utilization among drug using prisoners reentering the community. J Behav Health Serv Res (2006) 1.18

Partner relationships and HIV risk behaviors among women offenders. J Psychoactive Drugs (2008) 1.16

Multiple Determinants of Specific Modes of Prescription Opioid Diversion. J Drug Issues (2011) 1.15

HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida. AIDS Behav (2006) 1.15

Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. J Addict Med (2010) 1.15

Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend (2010) 1.15

Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) (2012) 1.15

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15

Prescription opioid abuse among drug-involved street-based sex workers. J Opioid Manag (2007) 1.13

A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage (2006) 1.13

iSyTE: integrated Systems Tool for Eye gene discovery. Invest Ophthalmol Vis Sci (2012) 1.11

Assessment of the abuse of tapentadol immediate release: the first 24 months. J Opioid Manag (2012) 1.11

Changing patterns of cocaine use and hiv risks in the south of Brazil. J Psychoactive Drugs (2006) 1.11

Collaborative Behavioral Management for Drug-Involved Parolees: Rationale and Design of the Step'n Out Study. J Offender Rehabil (2008) 1.10

A multistate trial of pharmacy syringe purchase. J Urban Health (2004) 1.09

The impact of intimate partner violence on women's condom negotiation efficacy. J Interpers Violence (2011) 1.08

HIV risk behaviors among rural stimulant users: variation by gender and race/ethnicity. AIDS Educ Prev (2007) 1.08

Diversion and abuse of methadone prescribed for pain management. JAMA (2005) 1.07

Prescription Drug Abuse & Diversion: Role of the Pain Clinic. J Drug Issues (2010) 1.07

Treatment during transition from prison to community and subsequent illicit drug use. J Subst Abuse Treat (2005) 1.06

Alcohol and drug use among rural and urban incarcerated substance abusers. Int J Offender Ther Comp Criminol (2002) 1.06

The role of public exposure in moral and nonmoral shame and guilt. J Pers Soc Psychol (2002) 1.06

Relationship influence and health risk behavior among re-entering women offenders. Womens Health Issues (2011) 1.05

Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA. AIDS Care (2013) 1.05

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf (2009) 1.04

An effective HIV risk-reduction protocol for drug-using female sex workers. J Prev Interv Community (2010) 1.03

Lack of HIV seropositivity among a group of rural probationers: explanatory factors. J Rural Health (2006) 1.02

Substance abuse among rural and very rural drug users at treatment entry. Am J Drug Alcohol Abuse (2006) 1.01

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01

OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med (2012) 1.00

Integrating an HIV/HCV brief intervention in prisoner reentry: results of a multisite prospective study. J Psychoactive Drugs (2008) 1.00

Prevalence of narcotic analgesic abuse among students: individual or polydrug abuse? Arch Pediatr Adolesc Med (2004) 1.00

Prescription opiate misuse among rural stimulant users in a multistate community-based study. Am J Drug Alcohol Abuse (2009) 1.00

Health, mental health, substance use, and service utilization among rural and urban incarcerated women. Womens Health Issues (2007) 0.99

Predictors of substance abuse treatment entry among rural illicit stimulant users in Ohio, Arkansas, and Kentucky. Subst Abus (2010) 0.98

Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations. J Subst Abuse Treat (2012) 0.98

Risky relationships: targeting HIV prevention for women offenders. AIDS Educ Prev (2012) 0.98

Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. J Rural Health (2006) 0.97

Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Saf (2014) 0.97

Rural and urban similarities and differences in private substance abuse treatment centers. J Psychoactive Drugs (2004) 0.96

Treatment retention predictors of drug court participants in a rural state. Am J Drug Alcohol Abuse (2004) 0.95

A comparison of rural and urban nonmedical prescription opioid users' lifetime and recent drug use. Am J Drug Alcohol Abuse (2012) 0.94

Substance use and sexual risk mediated by social support among Black men. J Community Health (2013) 0.94

Factors predicting unmet health services needs among incarcerated substance users. Subst Use Misuse (2006) 0.94

Methamphetamine use and adverse consequences in the rural southern United States: an ethnographic overview. J Psychoactive Drugs (2006) 0.94

Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N Engl J Med (2005) 0.93

Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. J Exp Criminol (2009) 0.93